BMS3052 - Biomedical basis and epidemiology of human disease

This unit will have a combined approach and examine the biomedical and epidemiological impacts of human disease on society. It will concentrate on the pathobiological and biomedical basis of prevalent human disease processes. Relevant areas examined in this unit may change from year to year but will generally include immune and inflammatory diseases, (e.g. inflammatory renal and joint disease); cancer biology (focussing on mechanisms of tumour spread); cardiovascular biology, (coronary heart disease/cerebrovascular disease); diabetes, obesity and neurological diseases. Disease pathogenesis, including lessons gained from cell/molecular biology and disease models will be the major focus. Concurrently, the epidemiological/clinical features of each disease, current treatments, challenges and future treatment prospects, including clinical trials will be covered highlighting the importance of an evidence-based approach to health care. This will discuss the complexities behind treatment based decision making by reviewing the evidence- base and understanding the criteria for deciding on what is best evidence. This unit will consider the biomedical basis and epidemiology in the context of the Australian health care system, including the Pharmaceutical Benefits Scheme (PBS), health policy and service delivery systems, putting illness and health in the context of social, cultural and behavioural systems.